Extracellular Vesicle-Enriched Secretome of Cardiovascular Progenitor Cells(Assistance Publique Hopitaux De Paris)

N/A

Report date: 2023/03/20 20:00:20

Base Information

Drug NameExtracellular Vesicle-Enriched Secretome of Cardiovascular Progenitor Cells(Assistance Publique Hopitaux De Paris)
Drug Alias NameExtracellular vesicle-enriched secretome of cardiovascular progenitor cells differentiated from induced pluripotent stem cells(Assistance Publique Hopitaux De Paris)
ClassificationBiologics > Protein drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHeart Failure, Systolic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsHeart Failure, Systolic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A